Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-23-004430

Chief Legal and HR Officer sold 2,248 shares at $19.30 ($43,386)

  • Chief Legal and HR Officer acquired 1,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bizily Scott · Chief Legal and HR Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-01 Exercise or conversion : show line 1 in the form +1,875 $6.49 $12,169 4,357 D
2023-03-01 Sale : show line 2 in the form −2,248 $19.30 $43,386 2,109 D
Open-market sales · 2,248 sh · avg $19.30 · $43,386

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-01 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −1,875 20,250 D
Loading xslF345X03/doc1.xml…